MAPPING OF SEQUENTIAL EPITOPES RECOGNIZED BY MONOCLONAL-ANTIBODIES ON THE BOVINE LEUKEMIA-VIRUS EXTERNAL GLYCOPROTEINS EXPRESSED IN ESCHERICHIA-COLI BY MEANS OF ANTIPEPTIDE ANTIBODIES

被引:18
作者
BAN, J
CZENE, S
ALTANER, C
CALLEBAUT, I
KRCHNAK, V
MERZA, M
BURNY, A
KETTMANN, R
PORTETELLE, D
机构
[1] RES INST FEED SUPPLEMENTS & VET DRUGS, CS-25449 JILOVE, CZECHOSLOVAKIA
[2] FAC AGRON GEMBLOUX, MOLEC BIOL UNIT, B-5030 GEMBLOUX, BELGIUM
[3] BIOMED CTR, S-75123 UPPSALA, SWEDEN
[4] FAC AGRON GEMBLOUX, MICROBIOL UNIT, S-75123 UPPSALA, SWEDEN
[5] FAC AGRON GEMBLOUX, B-5030 GEMBLOUX, BELGIUM
关键词
D O I
10.1099/0022-1317-73-9-2457
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A lambda-gt11 cDNA library prepared from bovine leukaemia virus (BLV)-producing ovine cells was screened with a cocktail of anti-BLV gp51 monoclonal antibodies (MAbs). Four recombinant phages with inserts of about 2 . 5 kbp were isolated. One, lambda-BLV-gp51-1, was sequenced and shown to encode the C-terminal part of gp51 and all of gp30. This insert was subcloned into pEV-vrf1 and expressed in Escherichia coli N-4830-1 cells. The BLV product and a series of antipeptide antibodies were used to localize the sequential epitopes defined on BLV envelope glycoprotein gp51 by their reactivity with MAbs. Epitope B was localized to amino acids 180 to 205, B' to residues 195 to 205, D and D' to residues 218 to 237, and A to amino acids 249 to 260. All the mapped sequential epitopes were localized in the C-terminal half of BLV gp51. The results of epitope mapping with bacterially produced gp51 confirm the map obtained using native viral glycoprotein.
引用
收藏
页码:2457 / 2461
页数:5
相关论文
共 17 条
[1]  
ALTANER C, 1985, FOLIA BIOL-PRAGUE, V31, P107
[2]   PROTECTIVE VACCINATION AGAINST BOVINE LEUKEMIA-VIRUS INFECTION BY MEANS OF CELL-DERIVED VACCINE [J].
ALTANER, C ;
BAN, J ;
ALTANEROVA, V ;
JANIK, V .
VACCINE, 1991, 9 (12) :889-895
[3]   MONOCLONAL-ANTIBODIES DEFINE 8 INDEPENDENT ANTIGENIC REGIONS ON THE BOVINE LEUKEMIA-VIRUS (BLV) ENVELOPE GLYCOPROTEIN-GP51 [J].
BRUCK, C ;
MATHOT, S ;
PORTETELLE, D ;
BERTE, C ;
FRANSSEN, JD ;
HERION, P ;
BURNY, A .
VIROLOGY, 1982, 122 (02) :342-352
[4]   TOPOGRAPHICAL ANALYSIS BY MONOCLONAL-ANTIBODIES OF BLV-GP51 EPITOPES INVOLVED IN VIRAL FUNCTIONS [J].
BRUCK, C ;
PORTETELLE, D ;
BURNY, A ;
ZAVADA, J .
VIROLOGY, 1982, 122 (02) :353-362
[5]  
Burny A., 1990, Retrovirus biology and human disease., P9
[6]   IODOACETAMIDE TREATMENT OF BOVINE LEUKEMIA-VIRUS GLYCOPROTEIN GP51 ENHANCES THE WESTERN BLOTTING REACTIVITY OF ANTIPEPTIDE ANTIBODIES [J].
CALLEBAUT, I ;
BURNY, A ;
PORTETELLE, D .
FEBS LETTERS, 1991, 292 (1-2) :148-150
[7]   USE OF SYNTHETIC PEPTIDES TO MAP SEQUENTIAL EPITOPES RECOGNIZED BY MONOCLONAL-ANTIBODIES ON THE BOVINE LEUKEMIA-VIRUS EXTERNAL GLYCOPROTEIN [J].
CALLEBAUT, I ;
BURNY, A ;
KRCHNAK, V ;
GRASMASSE, H ;
WATHELET, B ;
PORTETELLE, D .
VIROLOGY, 1991, 185 (01) :48-55
[8]   VERSATILE EXPRESSION VECTORS FOR HIGH-LEVEL SYNTHESIS OF CLONED GENE-PRODUCTS IN ESCHERICHIA-COLI [J].
CROWL, R ;
SEAMANS, C ;
LOMEDICO, P ;
MCANDREW, S .
GENE, 1985, 38 (1-3) :31-38
[9]   SEQUENCE VARIABILITY OF BOVINE LEUKEMIA-VIRUS ENV GENE AND ITS RELEVANCE TO THE STRUCTURE AND ANTIGENICITY OF THE GLYCOPROTEINS [J].
MAMOUN, RZ ;
MORISSON, M ;
REBEYROTTE, N ;
BUSETTA, B ;
COUEZ, D ;
KETTMANN, R ;
HOSPITAL, M ;
GUILLEMAIN, B .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4180-4188
[10]   RECOMBINANT VACCINIA VIRUS EXPRESSION OF THE BOVINE LEUKEMIA-VIRUS ENVELOPE GENE AND PROTECTION OF IMMUNIZED SHEEP AGAINST INFECTION [J].
PORTETELLE, D ;
LIMBACH, K ;
BURNY, A ;
MAMMERICKX, M ;
DESMETTRE, P ;
RIVIERE, M ;
ZAVADA, J ;
PAOLETTI, E .
VACCINE, 1991, 9 (03) :194-200